The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival
Pasquale L. Fedele, Yang Liao, Jianan Gong, Yuan Yao, Mark F. van Delft, Michael Löw, Lin Tai, Marco J. Herold, Jacob T. Jackson, Charis E. Teh, Tania Tan, Lorraine A. O’Reilly, Julie Tellier, George Grigoriadis, David C.S. Huang, Wei Shi, Stephen L. Nutt, Simon N. Willis
Topics & Concepts
Transcription factorIRF4Multiple myelomaCancer researchBiologyOncologyMedicineGeneticsImmunologyGeneMultiple Myeloma Research and TreatmentsSignaling Pathways in DiseaseCancer Mechanisms and Therapy